Healthcare

OrenAI: The first breast imaging cancer detection platform fusing AI + AR + Voice

OrenAI Healthcare

OrenAI

Revolutionary breast imaging cancer detection platform that combines artificial intelligence, augmented reality, and voice technology—the first innovation to fuse these three technologies for medical diagnostics.

AI-Powered Detection

Advanced machine learning models analyze breast imaging with unprecedented accuracy, identifying early-stage cancers that traditional methods might miss.

Augmented Reality Visualization

AR technology provides clinicians with immersive 3D visualizations of imaging data, enabling better spatial understanding and more precise analysis.

Voice-Enabled Interface

Natural language voice commands allow hands-free operation, improving workflow efficiency and reducing examination time while maintaining accuracy.

AI Detection
AR Visualization
Voice Interface

The Urgent Need

1 in 8

Women will develop invasive breast cancer in their lifetime. Early detection is critical—5-year survival rates drop from 99% (stage 0-1) to 27% (stage 4).

20-30%

Of breast cancers are missed in traditional mammography screenings. AI-enhanced detection can reduce false negatives by up to 9.4% (Nature Medicine, 2023).

43,000+

Women die from breast cancer annually in the US alone. AR-assisted visualization and voice-enabled workflows can accelerate diagnosis by 30%, saving lives.

Why GammaLex & OrenAI

GammaLex is the first to fuse AI, AR, and Voice technologies in breast imaging—a groundbreaking innovation that addresses the critical gap in early cancer detection. Our deep vertical AI expertise in healthcare, combined with cutting-edge multimodal fusion, enables clinicians to detect cancers earlier, reduce false negatives, and improve patient outcomes. OrenAI represents the future of precision diagnostics, where technology amplifies human expertise rather than replacing it.

Research & Articles

NCI: The Urgent Need for AI-Enhanced Breast Cancer Screening

The National Cancer Institute emphasizes the critical importance of accelerating AI adoption in breast imaging, citing evidence that AI-enhanced screening can detect cancers earlier and reduce mortality rates. The fusion of AI, AR, and voice technologies represents a groundbreaking approach to improving patient outcomes.

Read on NCI →